LEGAL ASPECTS OF DIRECT-TO-CONSUMER GENETIC TESTS.
Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2011, Vol 17, Issue 1
Abstract
Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on a genetic disorder. The main difference between direct-to-consumer genetic testing and the standard genetic testing is the way informational support is provided in internet offers of testing. Counselling may be offered as an additional special service at extra costs and at the customer's request. It may also be that a recommendation or at least an offer is given for the customer to contact a doctor or health practitioner from the company via phone for counselling. In a liberal society the fundamental individual rights can be considered to include access to medical treatment and diagnostics that may be helpful for improving one's health condition or that can help an individual make decisions regarding life style and health. At the European level, there are no binding legal regulations that specifically apply for genetic testing. In some European counties, national laws, require a responsible medical person to be involved before a genetic test is provided. The Convention on Human Rights and Biomedicine was adopted by the Committee of Ministers on 19 November 1996, while an Additional Protocol to the Convention, concerning Genetic Testing for Health Purposes, was adopted by the Committee of Ministers on 7 May 2008. Direct-to-consumer genetic testing is closely watched by the community of medical genetics and counsellors, and the EU funded Eurogentest Network of Excellence. In 2010, the European Society of Human Genetics has releaseda statement on direct-to-consumer gene testing for health-related purposes. The European Society of Human Genetics is concerned about the way in which commercial companies are currently introducing genetic tests into the market outside of the scope of the traditional healthcare system.
Authors and Affiliations
Mariela Yaneva – Deliverska
Keywords
Related Articles
- EP ID EP131033
- DOI 10.5272/jimab.2011171.135
- Views 123
- Downloads 0
ENDODONTIC TREATMENT OF LOWER LATERAL INCISOR WITH THREE ROOT CANALS – CASE REPORT.
The main goal of endodontic treatment is the correct diagnosis, optimal mechanical and chemical preparation and three-dimensional obturation of the root canal. Reasons for endodontic failure can be variations in th...
POST-STROKE COGNITIVE IMPAIRMENT – PHENOMENOLOGY AND PROGNOSTIC FACTORS
Stroke patients are at higher risk of developing cognitive impairment. Cognitive dysfunctions, especially progressive ones, worsen stroke prognosis and outcome. A longitudinal follow-up of cognitive disorders, however, i...
VECTOR BORNE TRANSMISSIBLE ZOONOSES IN MONTENEGRO
Vector borne transmissible zoonoses are becoming more and more important in the group of emerging and re-emerging infections. We present the characteristics and actuality of this group of infectious diseases in Montenegr...
BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
Objective: Bevacizumab improved survival when added to chemotherapy for patients with metastatic colorectal cancer (mCRC). The aim of this study was to explore the efficacy and safety of Bevacizumab containing chem...
FOLIC ACID AND VITAMIN B12 LEVELS IN BULGARIAN PATIENTS WITH BURNING MOUTH SYNDROME.
Actually the burning mouth syndrome (BMS) can be classified as idiopathic and secondary. The deficiency of vitamins (especially the group B) can be involved in BMS. In a group of 92 consecutive Bulgarian patients without...